Latest News

Epilepsy community seeks redefinition of bioequivalence from FDA

For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration?s (FDA) definition of bioequivalence as it applies to narrow therapeutic index (NTI) drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Protein glue shows potential for use with biomaterials

  • Respiratory infection controls being used for Ebola patients are unnecessary, may contribute to public panic

  • Obese or overweight teens more likely to become smokers

  • Evidence mounting that older adults who volunteer are happier, healthier

  • Training your brain to prefer healthy foods

  • No cookie-cutter divorces, so what info should online co-parenting classes offer?

  • Healthy working environment is a salvation

  • Warm thanks: Gratitude can win you new friends

  • Learning to read: Tricking the brain

  • Meaningful relationships can help you thrive

  •